Effects of chronic treatment with angiotensin converting enzyme inhibitor or an angiotensin receptor antagonist in two-kidney, one-clip hypertensive rats.

作者: Akiko Imamura , Harald S. Mackenzie , Eric R. Lacy , Florence N. Hutchison , Wayne R. Fitzgibbon

DOI: 10.1038/KI.1995.196

关键词:

摘要: Effects of chronic treatment with angiotensin converting enzyme inhibitor or an receptor antagonist in two-kidney, one-clip hypertensive rats. The effects II (Ang II) blockade (losartan) inhibition (enalapril) on blood pressure (BP), urinary albumin excretion (U alb V), renal histology and the hemodynamic excretory function clipped nonclipped kidneys were studied (2-K 1-C) One day after clipping right artery, male Wistar rats divided into three groups receiving: (1) losartan, 20 mg/kg/day (N = 7), (2) enalapril, 8), (3) no (controls, N=9) for weeks. Both losartan enalapril treatments maintained conscious BP at comparably lowered levels compared to control animals (116 ± 6mm Hg 113 2mm vs. 188 11mm Hg, respectively, P V, observed untreated group, weeks (1.7 0.5 0.7 0.1 mg/24 hr 17.8 7 hr, V from was approximately 5- 10-fold higher than treated groups. Histological evaluation revealed evidence early glomerulosclerosis but not groups, decreased indices glomerular size mesangial expansion group. These data support a primary role Ang modulation kidney 2-K 1-C rat.

参考文章(31)
Arthur C. Guyton, Thomas G. Coleman, Allen W. Cowley, Konrad W. Scheel, R.Davis Manning, Roger A. Norman, Arterial pressure regulation The American Journal of Medicine. ,vol. 52, pp. 584- 594 ,(1972) , 10.1016/0002-9343(72)90050-2
L. Gabriel Navar, P. Darwin Bell, Andrew P. Evan, The Regulation of Glomerular Filtration Rate in Mammalian Kidneys Springer, Boston, MA. pp. 593- 627 ,(1978) , 10.1007/978-1-4613-2097-5_36
R. R. Wexler, A. L. Johnson, D. J. Carini, P. C. Wong, P. B. M. W. M. Timmermans, A. T. Chiu, W. A. Price, J. V. Duncia, Nonpeptide angiotensin II receptor antagonists. IX. Antihypertensive activity in rats of DuP 753, an orally active antihypertensive agent. Journal of Pharmacology and Experimental Therapeutics. ,vol. 252, pp. 726- 732 ,(1990)
R. R. Wexler, A. L. Johnson, D. J. Carini, P. C. Wong, P. B. M. W. M. Timmermans, A. T. Chiu, W. A. Price, J. V. Duncia, Nonpeptide angiotensin II receptor antagonists. VIII. Characterization of functional antagonism displayed by DuP 753, an orally active antihypertensive agent. Journal of Pharmacology and Experimental Therapeutics. ,vol. 252, pp. 719- 725 ,(1990)
J�rgen F�hr, J�zef Kaczmarczyk, Claus-Dietrich Kr�ttgen, Eine einfache colorimetrische Methode zur Inulinbestimmung für Nieren-Clearance-Untersuchungen bei Stoffwechselgesunden und Diabetikern Journal of Molecular Medicine. ,vol. 33, pp. 729- 730 ,(1955) , 10.1007/BF01473295
S Anderson, H G Rennke, B M Brenner, Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. Journal of Clinical Investigation. ,vol. 77, pp. 1993- 2000 ,(1986) , 10.1172/JCI112528
Helmut G. Rennke, Philip S. Klein, Pathogenesis and significance of nonprimary focal and segmental glomerulosclerosis. American Journal of Kidney Diseases. ,vol. 13, pp. 443- 456 ,(1989) , 10.1016/S0272-6386(89)80001-0